list of fda approved covid tests

Some antibody tests use blood samples from a finger stick. On April 20, 2021, the FDA issued an amendment allowing certain authorized molecular diagnostic SARS-CoV-2 tests to be distributed and used to pool anterior nasal respiratory specimens from. Viral tests look for a current infection with SARS-CoV-2, the virus that causes COVID-19, by testing specimens from your nose or mouth. The FDA has determined that establishing additional conditions is necessary to mitigate the potential risk of false negative results due to either decreased sensitivity or non-reactivity associated with SARS-CoV-2 viral mutations. (August 2022) During the discussion, Watters asked DeSantis to respond to Donald Trump's comments about him in recent weeks. The templates reflect the FDA's current thinking on the data and information that developers should submit to facilitate the EUA process. 263a, that meet requirements to perform high complexity tests. Before sharing sensitive information, make sure you're on a federal government site. Please discuss this issue on the article's talk page. . The .gov means its official.Federal government websites often end in .gov or .mil. Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs, Remote or Wearable Patient Monitoring Devices EUAs, Ventilators and Ventilator Accessories EUAs, Emergency Use Authorizations for Medical Devices, In Vitro Diagnostics EUAs - Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Molecular Diagnostic Tests for SARS-CoV-2, Individual EUAs for Serology and Other AdaptiveImmune Response Tests for SARS-CoV-2, Umbrella EUA for Independently Validated Serology Tests for SARS-CoV-2, Historical Information about Device Emergency Use Authorizations: In Vitro Diagnostics (IVD), EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA (IgG), Letter Granting EUA Revision(s) (March 1, 2022), Letter Granting EUA Amendment(s) (May 9, 2020), Letter Granting EUA Amendment(s) (June 22, 2020), Letter Granting EUA Revision(s) (September 18, 2020), Letter Granting EUA Revision(s) (December 1, 2020), Viral Mutation Revision Letter (September 23, 2021), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack, Letter Granting EUA Revision(s) (October 30, 2020), Letter Granting EUA Revision(s) (January 29, 2021), Letter Granting EUA Amendment(s) (July 22, 2020), Letter Granting EUA Revision(s) (October 19, 2020), Letter Granting EUA Revision(s) (October 7, 2021), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack, Letter Granting EUA Revision(s) (May 20, 2020), Letter Granting EUA Revision(s) (October 23, 2020), Letter Granting EUA Amendment(s) (July 21, 2020), Letter Granting EUA Revision(s) (February 25, 2022), New York SARS-CoV Microsphere Immunoassay for Antibody Detection, Letter Granting EUA Amendment(s) (June 4, 2020), Letter Granting EUA Revision(s) (July 13, 2021), COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma), RightSign COVID-19 IgG/IgM Rapid Test Cassette, Letter Granting EUA Amendment(s) (July 23, 2020), Letter Granting EUA Revision(s) (August 31, 2020), Dimension Vista SARS-CoV-2 Total antibody assay (COV2T), Letter Granting EUA Amendment(s) (August 7, 2020), Dimension EXL SARS-CoV-2 Total antibody assay (CV2T), Letter Granting EUA Revision(s) (April 21, 2022), Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit, Letter Granting EUA Amendment(s) (August 3, 2020), Letter Granting EUA Revision(s) (October 17, 2020), LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold), Letter Granting EUA Revision(s) (August 12, 2020), Letter Granting EUA Revision(s) (December 2, 2020), Letter Granting EUA Revision(s) (February 14, 2022), Assure COVID-19 IgG/IgM Rapid Test Device, Letter Granting EUA Revision(s) (January 31, 2022), Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette, Letter Granting EUA Revision(s) (July 12, 2021), Letter Granting EUA Revision(s) (March 9, 2022), BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test, Letter Granting EUA Revision(s) (November 6, 2020), Letter Granting EUA Revision(s) (October 31, 2020), Letter Granting EUA Revision(s) (March 19, 2021), BioCheck SARS-CoV-2 IgG and IgM Combo Test, Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test, Letter Granting EUA Revision(s) (November 2, 2021), Letter Granting EUA Revision(s) (November 19, 2021), BioCheck SARS-CoV-2 IgM Antibody Test Kit, BioCheck SARS-CoV-2 IgG Antibody Test Kit, Letter Granting EUA Revision(s) (November 10, 2020), Letter Granting EUA Revision(s) (November 5, 2021), Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit, OmniPATH COVID-19 Total Antibody ELISA Test, Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2, cPass SARS-CoV-2 Neutralization Antibody Detection Kit, Letter Granting EUA Revision(s) (February 1, 2022), COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit, Letter Granting EUA Revision(s) (May 4, 2021), Letter Granting EUA Revision(s) (February 9, 2022), Letter Granting EUA Revision(s) (August 24, 2022), Innovita 2019-nCoV Ab Test (Colloidal Gold), Letter Granting EUA Revision(s) (June 28, 2021), MidaSpot COVID-19 Antibody Combo Detection Kit, Letter Granting EUA Revision(s) (January 25, 2021), Letter Granting EUA Revision(s) (February 5, 2021), Letter Granting EUA Revision(s) (April 12, 2021), Letter Granting EUA Revision(s) (July 29, 2021), Letter Granting EUA Revision(s) (April 2, 2021), Letter Granting EUA Revision(s) (April 26, 2021), Letter Granting EUA Revision(s) (July 21, 2022), COVID-19 Self-Collected Antibody Test System, Letter Granting EUA Revision(s) (June 24, 2021), ZEUS ELISA SARS-CoV-2 Total Antibody Test System, Letter Granting EUA Revision(s) (February 28, 2022), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Quantitative Reagent Pack used in combination with the VITROS Immunodiagnostic Products Anti- SARS-CoV-2 IgG Quantitative Calibrator, Letter Granting EUA Revisions(s) (September 8, 2021, Letter Granting EUA Revisions(s) (June 29, 2022), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total N Reagent Pack used in combination with the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total N Antibody Calibrators, Letter Granting EUA Revision(s) (August 31, 2022), Diazyme SARS-CoV-2 Neutralizing Antibody CLIA Kit, SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests, IgG, Lateral Flow, Fingerstick Whole Blood, Wadsworth Center, New York State Department of Health, IgM and IgG Lateral Flow, Fingerstick Whole Blood, ThermoGenesis SARS-CoV-2 IgM/IgG Antibody Test Kit, IgM and IgG, Lateral Flow, Fingerstick Whole Blood. Also in May, it received EUA from the FDA for a molecular COVID-19 test for use on the company's Alinity molecular laboratory instrument. When using a COVID-19 antigen diagnostic test, you should repeat testing following a negative result, whether you have symptoms or not, to reduce your risk of a false negative test result. However, antibody test results are not reported on the state's dashboard anyway. Test developers interested in pursuing an EUA may submit a pre-EUA to begin discussions with the FDA or may submit an EUArequest to CDRH-EUA-Templates@fda.hhs.gov. U.S. FDA 65%8. RT-PCR = reverse transcriptase polymerase chain reaction; LAMP = loop-mediated isothermal amplification; MALDI-TOF = Matrix Assisted Laser Desorption/Ionization - Time of Flight; TMA = Transcription Mediated Amplification; qSTAR = Selective Temperature Amplification Reaction; CRISPR = clustered regularly interspaced short palindromic repeats; Qualitative detection of RNA from SARS-CoV-2 in pooled samples containing up to [3, 5, or 10, depending on the applicable appendix] individual human anterior nasal swabs placed in a single vial containing transport media after being collected by a healthcare provider (HCP) or self-collected under the supervision of an HCP from any individual, including individuals without symptoms or other reasons to suspect COVID-19, when tested at least once per week as part of a serial testing program. Once you've confirmed your vitamin D levels via testing, adjust your sun exposure and/or vitamin D3 supplementation accordingly. IVDs can detect diseases or other conditions and can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Diagnostic tests can show if you currently are infected with SARS-CoV-2, the virus that causes COVID-19. For more information about how to reduce your risk of getting a false negative result on an at-home COVID-19 antigen test, read our FDA Safety Communication. The templates provide information and recommendations, and we plan to update them as appropriate as we learn more about the COVID-19 disease and gain experience with the EUA process for the various types of COVID-19 tests. Authorized at-home OTC tests are available without a prescription and are typically available online or at local stores. Find the original expiration date on the box label of your test and then look for the new expiration date in the "updated expiration dates" table for your test. There's a new federal resource to get free FDA-authorized coronavirus test kits. Negative results for severe acute respiratory syndrome coronavirus 2 and influenza B, if it is necessary for patient management, should be confirmed with an authorized molecular test performed in an approved laboratory, the FDA said. The expiration date is set at the end of the shelf-life. The test is to be performed two times over three days (serial testing). As new tests are authorized for use, they are added to these tables so that anyone can access up-to-date information on all authorized tests and collection kits. People with symptoms that began within the last 6 days. But the move came after tests last month showed the masks didn't meet standards. To increase the accuracy of an at-home COVID-19 antigen diagnostic test, it is important to perform repeat testing, after 48 hours, following a negative test result, whether you have symptoms or not, to reduce your risk of a false negative test result. 1 Authorized settings include the following: 2 Authorization Documents include the Healthcare Provider (HCP) and Patient Fact Sheets and either the Manufacture Instructions/Package Insert (abbreviated to IFU) or the EUA Summary. Where a test was previously authorized for testing of asymptomatic individuals (for example, individuals without symptoms or other epidemiological reasons to suspect COVID-19), the test is now authorized for use at least three times over five days with at least 48 hours between tests. Below is a list of the 11 tests currently approved by the FDA for use at home: The Food and Drug Administration has released the most current list of approved at-home COVID-19 tests. US Navy mulls adding info warfare specialists on more submarines. Antibody (or serology) tests look for antibodies in your blood that your immune system produced in response to SARS-CoV-2, the virus that causes COVID-19. Qualitative detection of RNA from SARS-CoV-2 in individual human anterior nasal swab samples collected by a healthcare provider (HCP) or self-collected under the supervision of an HCP from individuals, including individuals without symptoms or other reasons to suspect COVID-19, when tested at least once per week. For more information, including answers to frequently asked general questions about at-home COVID-19 diagnostic tests, visit At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions. Click here for a full list of FDA approved at-home COVID tests and their up-to-date expiration dates. Get hyperlocal forecasts, radar and weather alerts. The test is to be performed two times over three days (serial testing). The FDA is committed to helping ensure the public has access to a wide variety of test options for COVID-19. A molecular test detects the genetic material of SARS-CoV-2. The FDA released an initial version of this infographicfor 2020. A few weeks ago, a ProPublica reporter decided to test his kids for COVID-19. This table includes information about authorized SARS-CoV-2 serology/antibody tests and other adaptive immune response teststhat have been authorized individually. As the number of people wanting to get tested for COVID-19 ahead of the holidays has spiked in recent days, many people have gone looking for an alternative that doesn't involve sitting in a line of cars for hours at a time. Authorized devices in the table below are assigned the QKO product code. Go to COVIDtests.gov or call 1-800-232-0233 (TTY 1-888-720-7489) to order your free COVID test kits from the federal government. Tests available without a prescription include the attribute "DTC" (for direct-to-consumer home collection tests) or "OTC" (for over-the-counter at-home tests). These EUAs have been issued for each individual test with certain conditions of authorization required of the manufacturer and authorized laboratories. , Multiple Targets, RT-PCR, Microarray Hybridization, Home Collection, Multiple Targets, RT, Nested multiplex PCR, Multi-analyte, Multiple Targets, University of California, Los Angeles (UCLA), RT-PCR and electrochemical detection, Multi-analyte, Single Target, RT, qSTAR amplification, Home Collection, Screening, Pooling, Single Target, Real-Time RT-PCR, Pooling, Screening, Pooled Serial Screening - Swab, Multiple Targets, RT-PCR, chip array and MALDI-TOF Mass Spec, Multiple Targets, Prescription Home Testing, Multiple Targets, Express Gene LLC, DBA: Express Gene Molecular Diagnostics Laboratory, Real-time RT-PCR, Collection Kit, Saliva, Multiple Targets, Stanford Health Care Clinical Virology Laboratory, Laboratory Corporation of America (LabCorp), Direct to Consumer (DTC), Real-time RT-PCR, Home Collection, Pooling, Screening, Multiple Targets, RCA Laboratory Services LLC dba GENETWORx, ResearchDx, Inc., DBA Pacific Diagnostics, Real-time TMA, chemiluminescent, Multi-analyte, Multiple Targets, Isothermal Reverse Transcriptase - Helicase-Dependent Amplification (RT-HDA), Single Target, Hospital of the University of Pennsylvania, INNO Diagnostics Reference Laboratory, Ponce Medical School, Direct to Consumer (DTC), Real-time RT-PCR, Home Collection, Screening, Multiple Targets, Direct to Consumer (DTC), Real-time RT-PCR, Home Collection, Screening, Single Target, University of Illinois Office of the Vice President for Economic Development and Innovation, Real-time RT-PCR, Saliva, Serial Screening, Home Collection, Pooling, Multiple Targets, RT, Isothermal amplification, Over the Counter (OTC) Home Testing, Screening, Single Target, Clinical Research Sequencing Platform (CRSP), LLC at the Broad Institute of MIT and Harvard, Real-time RT-PCR, Home Collection, Pooled Serial Screening - Swab, Multiple Targets, Direct to Consumer (DTC), RT, LAMP, Home Collection, Screening, Multiple Targets, STS Lab Holdco (a subsidiary of Amazon.com Services LLC), Real-time RT-PCR, Home Collection, Pooling, Screening, Single Target, University of Louisville Infectious Diseases Laboratory, RT, LAMP, Over the Counter (OTC) Home Testing, Screening, Multiple Targets, Real-time RT-PCR, Screening, Pooled Serial Screening - Swab, Multiple Targets, Real-Time and End-Point RT-PCR, Multiple Targets, Synergy Diagnostic Laboratory, Inc., DBA SynergyDx, Southern California Permanente Medical Group, Real-Time RT-PCR, Saliva, Home Collection, Multiple Targets, RT-PCR, DNA Microarray Hybridization, Multiple Targets, Direct to Consumer (DTC), Home Collection Kit, Saliva, Screening, Multiple Targets, Real-time RT-PCR, Direct to Consumer (DTC), Screening, Salvia, Home Collection, Multiple Targets, Harvard University Clinical Laboratory (HUCL), Direct to Consumer (DTC), Real-time RT-PCR, Home Collection, Saliva Screening, Multiple Targets, Real-time RT-PCR, Multi-analyte, Home Collection, Single Target, Real-time RT-PCR, Screening, Home Collection, Multiple Targets, Life Technologies Corporation (a part of Thermo Fisher Scientific Inc.), Real-time RT-PCR, Home Collection, Screening, Single Target, Real-time RT-PCR, Home Collection, Multiple Targets, Screening, Direct to Consumer (DTC), Home Collection Kit, Screening, Direct to Consumer (DTC), Real-time RT-PCR, Home Collection, Pooling, Multiple Targets, Screening, Real-time RT-PCR, Home Collection, Multi-analyte, Multiple Targets, RT-LAMP, Serial Screening, Multiple Targets, Real-time RT-PCR, Quantitative, Multiple Targets, RT, Non-isothermal Nucleic Acid Amplification qSTAR, Multi-analyte, Single Target, ADL Diagnostics, Inc., dba Anavasi Diagnostics, The HFI Laboratory at Boston University (dba the BU Clinical Testing Laboratory), RT, LAMP, Over the Counter (OTC) Home Testing, Multi-analyte, Multiple Targets, Clinical Enterprise SARS-SoV-2-RT-PCR Assay, Helix Diagnostics SARS nCoV-2019 Multiplexed Assay, Rize Laboratory SARS nCoV-2019 Multiplexed Assay, Scope Molecular Laboratory SARS nCoV-2019 Multiplexed Assay, Infectious Disease Diagnostics Laboratory - Children's Hospital of Philadelphia, Hackensack University Medical Center (HUMC) Molecular Pathology Laboratory, Southwest Regional PCR Laboratory LLC. The FDA said it has authorized over 400 COVID-19 tests and collection kits - 235 molecular, 88 antibody, and 34 antigen tests -- to help ensure the public has access to a wide variety of. Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs, Remote or Wearable Patient Monitoring Devices EUAs, Ventilators and Ventilator Accessories EUAs, Emergency Use Authorizations for Medical Devices, Molecular Diagnostic Tests for SARS-CoV-2, Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2, Pooling and Serial Testing Amendment for Certain Molecular Diagnostic Tests for SARS-CoV-2, Umbrella EUA for SARS-CoV-2 Molecular Diagnostic Tests for Serial Testing, EUA for Molecular Diagnostic Tests for SARS-CoV-2 Developed And Performed By Laboratories Certified Under CLIA To Perform High Complexity Tests, Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, Antigen EUA Revision for Serial (Repeat) Testing, Individual EUAs for Diagnostic Breath Tests for SARS-CoV-2, Individual EUAs for Genotyping Tests for SARS-CoV-2, Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Individual EUAs for Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Molecular Diagnostic EUA Cover Sheet Template, Molecular Diagnostic Home Specimen Collection Template, Molecular and Antigen Home Use Test Template, Supplemental Template for Molecular and Antigen Diagnostic COVID-19 Tests for Screening with Serial Testing, Template for Serology Tests that Detect or Correlate to Neutralizing Antibodies, Policy for Coronavirus Disease-2019 Tests (Revised), Coronavirus (COVID-19) and Medical Devices, SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests. To see additional authorization documents, such as letters granting EUA amendments or revisions, and a list of other brand names authorized under a specific EUA, select the plus (+) button beside the "Date EUA Issued or Last Updated" for each EUA. designed to detect only one viral target on the SARS-CoV-2 genome; more susceptible to changes in performance due to viral mutations, meaning they are more likely to fail to detect new variants. There are different types of COVID-19 tests diagnostic tests and antibody tests. People with symptoms that began within the last 7 days. Antigen and Molecular Tests for COVID-19 The diagnostic testing field for COVID-19 is rapidly evolving, with many tests focused on diagnosing patients with active viral infections. Different tests are authorized to be used with different types of samples. Using the search box in the EUA tables, you can use keywords to search and filter the type of test or collection kit you are looking for. The .gov means its official.Federal government websites often end in .gov or .mil. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. . Antigen multi-analyte respiratory panel tests authorized in the table below are assigned the QMN product code. In May 2020, it received EUA from the FDA for another lab-based COVID-19 antibody test that helps detect the IgG antibody to SARS-CoV-2 using the company's Alinity i system. The EUA holder must also update their authorized labeling consistent with the revision letter and submit the labeling to the FDA within 3 months of September 23, 2021. Cases, data, and surveillance to track and analyze COVID-19. Our Spectrum News app is the most convenient way to get the stories that matter to you. Viral Mutation Revision Letter September 23, 2021. ORAL) saliva collection devices, Express Gene 2019-nCoV RT-PCR Diagnostic Panel, Gravity Diagnostics SARS-CoV-2 RT-PCR Assay, Pixel by LabCorp COVID-19 Test Home Collection Kit, Letter Granting EUA Revision(s) (April 1, 2022), Letter Granting EUA Revision(s) (July 8, 2022), Letter Granting EUA Revision(s) (November 1, 2022), Letter Granting EUA Revision(s) (February 12, 2021), Letter Granting EUA Revision(s) (November 17, 2021), Letter Granting EUA Revision(s) (February 24, 2021), Letter Granting EUA Revision(s) (February 14, 2023), Letter Granting EUA Revision(s) (March 9, 2021), Letter Granting EUA Revision(s) (March 25, 2021), Letter Granting EUA Revision(s) (May 5, 2022), Letter Granting EUA Revision(s) (April 30, 2021), Bio-Rad Reliance SARS-CoV-2 RT-PCR Assay Kit, Letter Granting EUA Revision(s) (March 3, 2021), BD MAX COVID-19 ASSAY (Authorized by HHS/OASH), PMSF-INNO SARS-CoV-2 RT-PCR Test (Authorized by HHS/OASH), Letter Granting EUA Revision(s) (March 4, 2022), Gravity Diagnostics SARS-CoV-2 RT-PCR for use with DTC kits, Everlywell COVID-19 Test Home Collection Kit DTC, Cue COVID-19 Test for Home and Over The Counter (OTC) Use, Letter Granting EUA Revision(s) (June 10, 2021), Letter Granting EUA Revision(s) (July 1, 2021), Letter Granting EUA Revision(s) (February 7, 2022), Letter Granting EUA Revision(s) (March 30, 2022), NxTAG Respiratory Pathogen Panel + SARS-CoV-2, Letter Granting EUA Revision(s) (January 4, 2023), CRSP SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Assay (Version 3), Pooling and Serial Testing Amendment for Certain Molecular Diagnostic Tests for SARS-CoV-2 -Amendment Letter, Gravity Diagnostics COVID-19 Test Home Collection Kit, Color COVID-19 Self-Swab Collection Kit DTC, Color SARS-CoV-2 RT-LAMP Diagnostic Assay DTC, NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay, Amazon Real-Time RT-PCR Test for Detecting SARS-CoV-2, Letter Granting EUA Revision(s) (December 17, 2021), SARS-CoV-2 real time RT-PCR test (Authorized by HHS/OASH), Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit, Letter Granting EUA Revision(s) (March 3, 2022), Letter Granting EUA Revision(s) (November 4, 2022), PerkinElmer SARS-CoV-2 RT-qPCR Reagent Kit, Clinical Enterprise SARS-CoV-2 RT-PCR Assay, Clinical Enterprise SARS-CoV-2 RT-PCR Assay DTC, Letter Granting EUA Revision(s) (May 6, 2021), Color COVID-19 Self-Swab Collection Kit with Saline, Letter Granting EUA Revision(s) (January 31, 2022), Letter Granting EUA Revision(s) (June 15, 2022), Biosearch Technologies SARS-CoV-2 Real-Time and End-Point RT-PCR Test, Letter Granting EUA Revision(s) (June 2, 2021), Kaiser Permanente High Throughput SARS-CoV-2 Assay, Pinpoint by Phosphorus COVID-19 Test Home Collection Kit DTC, WREN Laboratories COVID-19 Saliva Test Collection Kit DTC, cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System (cobas SARS-CoV-2), Everlywell COVID-19 & Flu Test Home Collection Kit, Letter Granting EUA Revision(s) (March 1, 2022), Letter Granting EUA Revision(s) (September 21, 2022), Letter Granting EUA Revision(s) (October 22, 2021), Kwokman Diagnostics COVID-19 Home Collection Kit, Life Sciences Testing Center COVID-19 Test, Letter Granting EUA Revision(s) (March 25, 2022), Letter Granting EUA Revision(s) (August 2, 2022), Letter Granting EUA Revision(s) (September 9, 2022), Letter Granting EUA Revision(s) (November 8, 2022), Quest COVID-19 PCR Test Home Collection Kit, Letter Granting EUA Revision(s) (July 7, 2022), Letter Granting EUA Revision(s) (October 6, 2022), Test Yourself DC At-Home COVID-19 Collection Kit, Letter Granting EUA Revision(s) (May 25, 2022), OPTI SARS-CoV-2/ Influenza A/B RT-PCR Test (Version 1 and Version 2), Labcorp Seasonal Respiratory Virus RT-PCR Test, Letter Granting EUA Revision(s) (November 23, 2022), cobas SARS-CoV-2 Duo for use on the cobas 6800/8800 Systems, Diversified Medical Healthcare SARS-CoV-2 Assay, Hi-Sense COVID-19 Molecular Testing Kit 1.0, BD Respiratory Viral Panel for BD MAX System, LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete Assay, The AscencioDx COVID-19 Test and The AscencioDx Molecular Detector.

How To Go From 90 To 100% Va Disability Rating, Henry Snyder Obituary, Benzie County Clean Up Day 2021, Articles L